Updates on clinical trials of intravenous vitamin C and other alternative therapies
No recent clinical trials have been published. However, a study in mice recently reported that daily intravenous vitamin C, which brought about blood levels of the compound that are similar to those observed in human studies of IV vitamin C administration, slowed the growth of human ovarian, pancreatic and brain tumors implanted in the animals.
Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9.http://www.ncbi.nlm.nih.gov/pubmed/18678913?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum